Related Experiment Video
Updated: Jun 21, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Achieving cholesterol goals. Current and future drug therapies
1Baylor College of Medicine, Houston, TX 77030, USA. jones@bcm.tmc.edu
Postgraduate Medicine
|August 12, 2009
Summary
Lowering low-density lipoprotein cholesterol (LDL-C) is crucial for patients with coronary heart disease (CHD). Rosuvastatin offers significant LDL-C reduction and is a promising option for lipid-lowering therapy.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Low-density lipoprotein cholesterol (LDL-C) management is critical for patients with coronary heart disease (CHD) and equivalent risk factors.
- Therapeutic goals for LDL-C are typically below 100 mg/dL for high-risk individuals.
Purpose of the Study:
- To review the role of statins in managing dyslipidemias.
- To highlight the efficacy of rosuvastatin in lowering LDL-C and increasing HDL-C.
Main Methods:
- Review of current guidelines and pharmacological data for lipid-lowering therapies.
- Comparison of the efficacy of approved statins, including the emerging drug rosuvastatin.
Main Results:
- Rosuvastatin demonstrates superior LDL-C reduction and HDL-C increase compared to other statins.
- Statins can be used as monotherapy or in combination with other agents like ezetimibe or niacin for mixed dyslipidemias.
Conclusions:
- Rosuvastatin represents a significant advancement in LDL-C lowering therapy.
- Effective lipid management strategies are essential for reducing cardiovascular risk.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...